Adverse pathology at radical prostatectomy, GPS™ test, and clinical/pathology features as predictors of long-term prostate cancer outcomes

by M.A. Brooks, L.J. Thomas, J.M. Abran, M. Crager, J. Li, R. Lu, E.A. Klein
Published 2020-07-01

Outcomes of men with ductal prostate cancer undergoing definitive therapy for localized disease

by W. Ranasinghe, D. Shapiro, C.A. Reichard, M. Elsheshtawi, Y. Nyame, D. Sundi, J. Tosoian, L. Wilkins, R. Alam, M.F. Achim, T. Bathala, C. Tang, A. Aparicio, S. Tu, N. Navone, L. Pisters, A.J. Stephenson, E.A. Klein, A.E. Ross, M.E. Allaf, J. Davis, B.F. Chapin
Published 2020-07-01

Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost: Comparison of outcomes in a multi-institutional analysis of patients with...

by A.U. Kishan, R.J. Karnes, T. Romero, G. Motterle, R.D. Tendulkar, E.A. Klein, J.K. Wong, E.M. Horwitz, J.D. Tward, R.T. Dess, T.B. Wedde, W.A. Lilleby, G.S. Merrick, R.G. Stock, D.J. Krauss, P.T. Tran, B.J. Moran, B.J. Stish, C. Reddy, R. Levin-Epstein, D. Elashaoff, D. Demanes, R.E. Reiter, D. Tilki
Published 2020-07-01